Smoking-Cessation.org Logo
Medical Treatment

Medication-Assisted Treatment (MAT) for Nicotine Addiction

FDA-approved quit-smoking medications paired with behavioral support

50%+
Higher quit success with medication
3
First-line cessation medications
7,000+
Centers offering cessation care
#1
First-line clinical recommendation
Updated: July 13, 2026
Verified Information

What is Medication-Assisted Treatment?

Medication-Assisted Treatment (MAT) combines FDA-approved cessation medications with counseling and behavioral support to treat nicotine addiction. This "whole-patient" approach eases the physical grip of withdrawal while therapy rebuilds the daily habits and routines that keep people smoking, producing far higher long-term quit rates than willpower alone.

The Science Behind Cessation Medications

Nicotine keeps smokers hooked by flooding the brain's reward system and then leaving it depleted between cigarettes—which is what withdrawal feels like. Cessation medications work on this cycle in three ways: nicotine replacement delivers a steady, low, non-inhaled dose that blunts withdrawal; bupropion adjusts brain chemistry to dampen cravings; and varenicline gently occupies nicotine receptors so a cigarette delivers far less of a reward.

This gives the brain time to reset while a person practices living smoke-free. Rather than simply swapping one habit for another, the medications are carefully dosed to reduce cravings without the sharp spikes that come from inhaled nicotine, then tapered as new routines take hold.

Medication Plus Counseling

Medication is only half of Medication-Assisted Treatment. National tobacco-cessation guidelines are clear that the strongest results come from pairing an FDA-approved medication with behavioral support—whether that is individual counseling, a group program, or a telephone quitline. The medication softens withdrawal; the counseling rebuilds the coping skills and trigger management that prevent relapse.

Used together, medication and counseling can roughly double a person's odds of staying quit compared with either approach on its own. That combined "whole-patient" model is why MAT is considered a first-line treatment for nicotine addiction rather than a last resort.

FDA-Approved Cessation Medications Evidence-Based Approach 7,000+ Treatment Centers

How MAT Works in Nicotine Addiction Treatment

MAT works best when medication is combined with structured behavioral support. That means pairing a cessation medication with individual counseling, group sessions, or a quitline, plus help with the stress, routines, and social situations that trigger smoking.

The Treatment Process

Treatment usually starts with a brief assessment to match the right medication and dose to a person's smoking history and health. Many people set a target quit date and begin medication one to two weeks beforehand—varenicline and bupropion in particular are started before the quit day, while nicotine replacement can begin on it.

Once medication is under way, ongoing counseling—often Cognitive Behavioral Therapy (CBT) and/or Motivational Interviewing—helps a person manage cravings, avoid triggers, and build the coping skills that keep a quit attempt from unraveling.

FDA-Approved Medications for Quitting Smoking

The FDA has approved three first-line pharmacotherapies for quitting smoking: nicotine replacement therapy, bupropion SR, and varenicline. Each works in a different way, and they can be matched—or combined—to a person's smoking pattern, preferences, and medical history.

Nicotine Replacement Therapy (NRT)

Nicotine Replacement Therapy (NRT) supplies a controlled, low dose of nicotine without the tar, carbon monoxide, and other toxins in smoke. It comes in five FDA-approved forms: the patch (a steady all-day dose), and gum, lozenge, inhaler, and nasal spray (faster relief for sudden cravings). A common, well-supported strategy is to combine the patch with a fast-acting form, giving a person both baseline coverage and something to reach for when a craving spikes.

NRT is available over the counter (patch, gum, lozenge) or by prescription (inhaler, nasal spray), and is designed to be tapered off over roughly 8 to 12 weeks as cravings fade.

Prescription Medications: Bupropion and Varenicline

Bupropion SR (Zyban) is a non-nicotine prescription pill that adjusts dopamine and norepinephrine signaling to reduce cravings and withdrawal. It is usually started one to two weeks before a target quit date and taken for 8 to 12 weeks. Because it can affect mood, providers review a person's mental-health history before prescribing it.

Varenicline (Chantix) is a non-nicotine prescription pill that partially activates nicotine receptors—easing withdrawal—while blunting the reward if a person does smoke. Started before a quit date and typically taken for 12 weeks, with an optional second course, varenicline is among the most effective single cessation medications in clinical trials.

Benefits of Medication-Assisted Treatment

Research consistently shows that Medication-Assisted Treatment improves quit outcomes across several measures:

  • Higher long-term quit rates—pairing medication with counseling can roughly double the odds of staying smoke-free
  • Smoother withdrawal—medications ease the irritability, restlessness, and cravings that peak in the first week
  • Better treatment engagement—people are more likely to stick with a structured quit plan
  • Fewer relapses—medication buys time for new, smoke-free routines to take hold
  • Rapid health gains—heart rate and blood pressure begin improving within days of the last cigarette
  • Flexible options—five NRT forms plus two prescription pills allow a plan tailored to each smoker
  • Broad insurance coverage—cessation medications are covered as a preventive benefit under most plans

Debunking Quit-Smoking Medication Myths

Despite strong evidence, cessation medications remain underused because of persistent myths. Here are the facts:

Myth Busting

"Nicotine replacement just keeps me addicted to nicotine." NRT delivers a low, steady, non-inhaled dose without the thousands of harmful chemicals in smoke, and it is meant to be tapered off. Studies show it eases withdrawal and improves quit rates rather than prolonging dependence.

"Real quitters use willpower alone." Most unaided quit attempts fail within the first week, when withdrawal peaks. Using a medication is not a sign of weakness—it is an evidence-based tool, and it works even better alongside peer support such as 12-step programs like Nicotine Anonymous.

"If I slip once, the medication has failed." A single slip is not the same as a full relapse. Quitting is often a process of several attempts, and staying on medication and in counseling after a slip is linked to better long-term success than stopping.

Who Benefits from MAT?

Medication-Assisted Treatment is recommended for most adults who smoke or use tobacco and want to quit. Certain groups tend to see especially strong benefits from adding medication:

  • Heavy or long-term smokers — people who smoke within an hour of waking or go through a pack or more a day often have stronger withdrawal, which medication helps manage
  • People who have tried to quit before — adding medication to a fresh attempt meaningfully improves the odds compared with willpower alone
  • Smokers with intense cravings or withdrawal — combining a nicotine patch with a fast-acting form, or using varenicline, can smooth the worst of it
  • People with co-occurring mental health conditions — many people who smoke also live with depression or anxiety, and medication plus counseling can address both the habit and the mood triggers behind it
  • Those quitting vaping or multiple tobacco products — the same first-line medications can support quitting beyond traditional cigarettes

There is no single "typical" patient. People of all ages, backgrounds, and smoking histories benefit. The right medication and plan should be chosen with your provider, based on your smoking history, health, and personal goals.

MAT at Different Levels of Care

One of MAT's strengths is flexibility — cessation medications fit into nearly every setting where nicotine addiction is treated, providing continuity as a person moves through recovery:

  • Primary Care and Clinics — Most quit attempts with medication begin here, where a provider can prescribe varenicline or bupropion and recommend nicotine replacement
  • Residential/Inpatient Treatment — When someone is in a program for a co-occurring condition, cessation medication can be added so tobacco is addressed alongside other care
  • Partial Hospitalization (PHP) — Structured daytime programs can incorporate cessation medication and counseling for people who need significant support
  • Intensive Outpatient (IOP) — Medication paired with IOP offers flexibility for people balancing work or family while building smoke-free routines
  • Standard Outpatient — The most common long-term setting, combining periodic check-ins with ongoing counseling and medication management
  • Telehealth and Quitlines — Many cessation medications and counseling sessions can now be accessed remotely, including free state quitlines, expanding access for rural areas

The key principle is continuity — staying on medication and in counseling through the first few months, when relapse risk is highest, gives new smoke-free habits the best chance to stick.

Not Sure Which Program Fits?

Search the directory or call to talk through your treatment options.

Call 1(251) 220-6222
11,800+ Centers
SAMHSA Data

What to Know About Medication-Assisted Treatment

Medication-Assisted Treatment (MAT) combines FDA-approved cessation medications — nicotine replacement therapy, bupropion SR, or varenicline — with counseling and behavioral support. It is a first-line, evidence-based way to treat nicotine addiction and ease the withdrawal that makes quitting hard.

No. Nicotine replacement delivers a steady, low, non-inhaled dose that eases withdrawal while you break the smoking habit, and is designed to be tapered off. Bupropion and varenicline contain no nicotine at all and work on brain chemistry to reduce cravings.

Most courses run about 8 to 12 weeks, though some people continue longer. Nicotine replacement and bupropion are commonly used for 8 to 12 weeks, and varenicline for 12 weeks, with an optional second course. Your provider can adjust the length to your needs.

The FDA has approved three first-line options: nicotine replacement therapy (patch, gum, lozenge, inhaler, and nasal spray), bupropion SR (Zyban), and varenicline (Chantix). Combining the patch with a faster-acting form like gum or lozenge is also common.

Yes. Most plans, including Medicaid and Medicare, cover FDA-approved cessation medications and counseling as a preventive benefit under the Affordable Care Act. Coverage details vary, so it is worth verifying your specific plan.

Yes. FDA-approved cessation medications do not cause impairment when taken as directed, so you can work, drive, and go about daily life normally. Report any unusual mood changes on varenicline or bupropion to your provider.

Medication works best paired with counseling. Combining an FDA-approved medication with behavioral support such as CBT or a quitline produces higher long-term quit rates than either approach used alone.

Nicotine withdrawal — irritability, restlessness, and intense cravings — peaks in the first week and drives many unaided quit attempts to fail. Medication smooths that curve, giving new habits and coping skills time to take hold.

Behavioral counseling is the recommended first step during pregnancy. If medication is considered, nicotine replacement may be used under close medical supervision. Always talk with your healthcare provider about the right option for you.

Use our search tool above to find treatment centers offering cessation medication, or call SAMHSA's helpline at 1-800-662-4357 for assistance.

Resources & Further Reading

Ready to Take the Next Step?

Browse our directory of centers offering medication-assisted treatment and connect with a program that fits your plan to quit.